Emil D. Kakkis, President & CEO at Ultragenyx Pharmaceutical Inc. (RARE), sold 46,342 shares at $141.80 ($6.6M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Seasonal sale ($6.6M) by President & CEO — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.80 | 30,000 | $4.3M | 64.6% |
| 2 | $142.47 | 16,342 | $2.3M | 35.4% |
| Total | $142.04 avg | 46,342 | $6.6M | 100% |
| Filing → |
| RARE | SELL | 2024-12-31 | $990K | — | Filing → |
| RARE | SELL | 2024-12-11 | $414K | — | Filing → |
| RARE | SELL | 2024-09-05 | $1.1M | — | Filing → |